Quest Diagnostics Boosts FY22 Outlook - Update

RTTNews | 924 days ago
Stocktwits
Quest Diagnostics Boosts FY22 Outlook - Update

(RTTNews) - While reporting financial results for the third quarter on Thursday, Quest Diagnostics Inc. (DGX) raised its earnings, adjusted earnings and revenue guidance for the full-year 2022, based on its strong performance in the quarter.

For fiscal 2022, the company now projects earnings in a range of $8.52 and $8.72 per share and adjusted earnings in a range of $9.75 and $9.95 per share on net revenues between $9.72 billion and $9.86 billion.

Previously, the company expected earnings in the range of $8.24 to $8.64 per share and adjusted earnings in the range of $9.55 to $9.95 per share on net revenues between $9.50 billion and $9.75 billion.

On average, 15 analysts polled by Thomson Reuters expect the company to report earnings of $9.68 per share on revenues of $9.67 billion for the year. Analysts' estimates typically exclude special items.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

Tags: DGX
Stocktwits
read more
Quest Diagnostics To Acquire Outreach Laboratory Services Of OhioHealth

Quest Diagnostics To Acquire Outreach Laboratory Services Of OhioHealth

Quest Diagnostics (DGX), a provider of diagnostic information services, and OhioHealth, a nationally recognized not-for-profit, charitable, integrated health system, announced Wednesday a definitive agreement for Quest to acquire select assets of OhioHealth's outreach laboratory services business.
RTTNews | 295 days ago
Quest Diagnostics To Acquire LifeLabs From OMERS In About $985 Mln Deal

Quest Diagnostics To Acquire LifeLabs From OMERS In About $985 Mln Deal

Quest Diagnostics (DGX), a provider of diagnostic information services, announced Wednesday a definitive agreement to acquire LifeLabs, a provider of community laboratory tests for millions of Canadians, from OMERS for a value of approximately C$1.35 billion (approximately $985 million), including net debt.
RTTNews | 302 days ago
Tools
Economic Calendar
Market Hours
Interest Rates
Holidays Calendar
Forex Market
Forex Volatility
Forex Correlation
Forex News
forex analysis
COT Data
Liquidity
Forex Calculators
Forex Heat Map
Indicators Heatmap
Community
Community
Systems
Most Popular Systems
Strategies
Contests
Forex Charts
Forex Sentiment
Sentiment Indicator
Reviews
Brokers
Prop Trading Firms
VPS Services
Signal Providers
EA Programming Services
Affiliate Programs
PAMM Broker Services
Rebate Program Services
Trading Platforms
Expert Advisors
Crypto Exchanges
Trading Courses
Brokers
Forex Spreads
Forex Broker Quotes
Forex Broker Swaps
Forex Broker Volume
Forex Broker Promotions Press Release
Platform
Widgets
Features
API
RSS
Stock Portfolio
Affiliate Software
Advanced Charts
Support
FAQ
Help
Contact Us
Report a Bug!
About
Blog
© 2025 Myfxbook Ltd. All Rights Reserved.
HIGH RISK WARNING: Foreign exchange trading carries a high level of risk that may not be suitable for all investors. Leverage creates additional risk and loss exposure. Before you decide to trade foreign exchange, carefully consider your investment objectives, experience level, and risk tolerance. You could lose some or all of your initial investment. Do not invest money that you cannot afford to lose. Educate yourself on the risks associated with foreign exchange trading, and seek advice from an independent financial or tax advisor if you have any questions. Any data and information is provided 'as is' solely for informational purposes, and is not intended for trading purposes or advice. Past performance is not indicative of future results.